GENTILI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.532
EU - Europa 379
AS - Asia 153
AF - Africa 39
SA - Sud America 4
Totale 2.107
Nazione #
US - Stati Uniti d'America 1.504
SE - Svezia 104
IT - Italia 83
DE - Germania 72
IN - India 59
FI - Finlandia 49
SG - Singapore 49
CN - Cina 44
BJ - Benin 33
UA - Ucraina 21
GB - Regno Unito 15
BG - Bulgaria 14
CA - Canada 14
AT - Austria 10
BZ - Belize 9
MX - Messico 5
TG - Togo 5
AR - Argentina 3
BE - Belgio 3
IE - Irlanda 3
RO - Romania 3
EC - Ecuador 1
KR - Corea 1
NL - Olanda 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 2.107
Città #
Fairfield 250
Ashburn 159
Woodbridge 118
Chandler 98
Seattle 92
Cambridge 80
Wilmington 62
Ann Arbor 58
Houston 58
Dearborn 54
Princeton 46
San Jose 40
Fasano 33
Frankfurt am Main 33
Plano 33
San Paolo di Civitate 32
Bremen 27
Singapore 27
Beijing 19
Lawrence 17
Millbury 17
Washington 17
Boston 16
Dallas 16
Helsinki 16
San Mateo 16
Los Angeles 15
San Diego 14
Sofia 14
Rome 13
Ottawa 11
Fremont 10
Jacksonville 10
Saint Louis 10
Belize City 9
Vienna 9
Auburn Hills 8
Boardman 7
Hefei 7
Norwalk 7
Chicago 6
Des Moines 6
Lomé 5
Andover 4
Columbus 4
Falls Church 4
Grafing 4
Brussels 3
Dublin 3
Federal 3
Toronto 3
Atlanta 2
Cardiff 2
Clifton 2
Indiana 2
Mexico City 2
Nanchang 2
Ningbo 2
Prescot 2
Santa Clara 2
Taizhou 2
Torre del Greco 2
Zhengzhou 2
Augusta 1
Baotou 1
Berlin 1
Bühl 1
Changsha 1
Chaoyang 1
Chengdu 1
Fuzhou 1
Guangzhou 1
Jinan 1
Kenmore 1
Lanzhou 1
Leawood 1
London 1
Mannheim 1
Muizenberg 1
Nanjing 1
Provo 1
Quito 1
Redwood City 1
Sacramento 1
Sesto Fiorentino 1
Southend 1
Xian 1
Totale 1.671
Nome #
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 93
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 93
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 89
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 88
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis 82
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 80
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 79
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 77
COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS 76
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 76
Nutritional status: its influence on the outcome of patients undergoing liver transplantation 75
Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation 74
THE PREDICTION OF CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION: A TIME-DEPENDENT ANALYSIS 73
VALIDATION OF A PREDICTIVE MODEL FOR CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION 72
Predictors of outcome of liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma 71
Hepatic steatosis after liver transplantation: Prevalence and associated factors 70
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 70
Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study 69
Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation 67
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis? 66
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 65
SHORT TERM EFFECTS OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS FORMULATION IN LIVER TRANSPLANT PATIENTS 60
Molecular mechanisms underlying muscle loss in cirrhotic patients 57
SEQUENTIAL CHANGES IN NUTRITIONAL STATUS, ENERGY EXPENDITURE, DIETARY INTAKE DURING THE FIRST SIX MONTHS AFTER LIVER TRANSPLANTATION 54
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 53
Estrado de nutrition, composicion corporal y metabolismo energetico en pacientes con cirrosis epatica 52
AUTOIMMUNE DE NOVO HEPATITIS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION 52
Actualidad en la pathogenesis y tratamiento de la encefalopatia epatica 49
AUTOIMMUNE DE NOVO HEPATITIS IN TRANSPLANTED PATIENTS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE 49
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE. 44
CALCINEURIN INHIBITORS REDUCTION IN LIVER TRANSPLANTED PATIENTS WITH CHRONIC RENAL DYSFUNCTION: RESULTS IN CURRENT CLINICAL PRACTICE 44
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE 31
FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 31
Totale 2.181
Categoria #
all - tutte 5.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020567 0 0 5 18 48 259 74 53 57 26 18 9
2020/2021136 17 21 7 12 1 4 2 13 13 8 2 36
2021/2022363 1 12 34 15 50 13 3 31 50 28 47 79
2022/2023435 67 83 38 96 42 35 9 12 38 7 6 2
2023/2024198 6 17 23 9 24 58 0 12 0 29 13 7
2024/202527 14 8 5 0 0 0 0 0 0 0 0 0
Totale 2.181